USPTO serial 99266882
PROVOLUT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 9, 2026
- Examiner
- JONES, JACQUELYN ANDREA
- Law office
- Historical data usage
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PROVOLUT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Katrin Lewertoff
Katrin Lewertoff Lewertoff IP Law Group, LLC16 East 34th Street18th FloorNew York, NY 10016Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Recorded and downloadable media and data, namely, recorded and downloadable datasets comprising protein sequence, structure, and function data for use in biotechnology and pharmaceutical research; Downloadable databases in the field of protein engineering, molecular biology, and drug discovery; Downloadable software for computational protein design, protein engineering, molecular simulation, and optimization of proteins, enzymes, and molecules for pharmaceutical and industrial biotechnology applications; Downloadable artificial intelligence software for protein design, protein optimization, drug candidate identification, and prediction of protein properties and downloadable software using machine learning for designing, analyzing, optimizing, and predicting the function and properties of proteins, enzymes, and molecules for use in pharmaceutical development and biotechnology; all the aforesaid goods relating to, [ in particular, ] synthetic biology, biotechnology, protein engineering, molecular sciences and the design, development and optimization of proteins, enzymes and molecules | ACTIVE | — |
| 042 | IT services, namely, IT consulting services relating to the implementation, integration, maintenance, and customization of software for computational biology, protein engineering, and drug design; development, programming and implementation of software for others; hosting services, namely, hosting cloud-based software platforms for computational protein design, molecular simulation, and drug discovery; platform-as-a-service (PaaS) featuring computer software platforms for computational protein engineering, machine-learning-driven protein optimization, and pharmaceutical drug candidate design and analysis; software-as-a-service (SaaS) services featuring software for AI-driven protein design, protein optimization, molecular engineering, and drug discovery; rental of computer software for computational protein design, protein optimization, molecular simulation, and drug development; design and development of computer hardware and software; scientific and technological services, namely, scientific research, computational analysis, and testing in the field of protein engineering, molecular biology, drug discovery, and biotechnology and scientific and technological research in the field of protein design, enzyme engineering, drug development, and precision oncology and design services relating thereto, namely, computational protein design, enzyme design, drug candidate design, and software design for biotechnology applications; industrial research in the field of biotechnology, protein engineering, and industrial enzyme development and industrial design services; quality control of goods and services and authentication in the field of protein and enzyme quality, pharmaceutical drug candidates, and biotechnological products; development of pharmaceutical products; Scientific laboratory services; laboratory research in the field of protein engineering, molecular biology, enzyme optimization, and pharmaceutical drug development; Scientific laboratory services; Computer software consultancy, information and information services in the field of computational biology, protein engineering, drug design, and biotechnology relating to the aforementioned services; all of the aforementioned services, [ in particular, ]in the field of synthetic biology, biotechnology, protein technology, molecular sciences and for the design, development and optimization of proteins, enzymes and molecules | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 20, 2026 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Sep 25, 2026 | A7OK | AMENDMENT UNDER SECTION 7 - PROCESSED | — |
| Sep 21, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 3, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 3, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 3, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 3, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 3, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 3, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 29, 2026 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Jun 9, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 9, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 21, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 21, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 15, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 24, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 24, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 24, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 24, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 24, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 21, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 9, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 3, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 3, 2025 | NWAP | NEW APPLICATION ENTERED | — |